Dr. Narender Kumar Thota

• Dr. Narender Kumar Thota is a leading hemato-oncologist with over 23 years of experience in treating blood cancers like leukemia, lymphoma, and multiple myeloma.
• He specializes in performing complex bone marrow and stem cell transplants, including high-risk procedures in children and adults.
• Known for his patient-centric approach, Dr. Thota combines compassion and clarity in consultations, ensuring patients and families feel supported throughout treatment.
• His commitment to innovation and research has helped establish advanced, affordable, and evidence-based care protocols for patients in India.

• Dr. Narender Kumar Thota is a highly qualified medical oncologist and hematologist, with specialized training in hematologic cancers and bone marrow transplantation.
• With advanced degrees from Kakatiya Medical College, Gandhi Medical College, and Nizam Institute of Medical Sciences, he has also completed a fellowship at the City of Hope, Los Angeles.
• Currently, Dr. Thota serves as a Consultant in Hemato-Oncology & Stem Cell Transplant at KIMS Krishna Institute of Medical Sciences, Hyderabad.
• He has contributed to clinical research with publications and case studies in hematologic malignancies, reflecting a strong academic foundation.
• Dr. Thota’s practice is known for offering advanced, empathetic, and patient-friendly care, reflecting his dedication to better outcomes in hemato-oncology.

Experience of Dr. Narender Kumar Thota

• Dr. Narender Kumar Thota has more than 23 years of experience in the field of Hemato-Oncology.

• MBBS, Kakatiya Medical College, Warangal (2002)
• MD in Internal Medicine, Gandhi Medical College, Hyderabad (2008)
• DM in Medical Oncology, Nizam Institute of Medical Sciences, Hyderabad (2012)
• Fellowship in Bone Marrow Transplant and Hematology, City of Hope, Los Angeles (2013)

• Proficient in treating complex blood cancers such as leukemia, lymphoma, and multiple myeloma, along with other hematologic disorders.
• Skilled in performing both autologous and allogeneic stem cell and bone marrow transplants, including high-risk and pediatric cases.
• Expert in modern therapies like immunotherapy, targeted chemotherapy, and precision medicine, ensuring advanced care for each patient.
• Focuses on comprehensive supportive care to manage treatment complications and improve quality of life for patients undergoing intensive therapies.
• Combines evidence-based treatments with a compassionate approach, delivering affordable and high-quality hematologic cancer care.

• English
• Telugu
• Kannada

• Indian Medical Association (IMA)
• Indian Society of Medical & Paediatric Oncology (ISMPO)
• American Society of Clinical Oncology (ASCO)
• European Society for Medical Oncology (ESMO)
• Indian Society of Hematology & Blood Transfusion
• European Haematology Association (EHA)
• American Society of Hematology (ASH)

• 2nd Prize – Oral Presentation on adult acute promyelocytic leukemia at ISMPO Vizag Meet, February 2012.
• Poster judged among the Best from India at ASCO, Chicago, June 2011, for work on Imatinib Mesylate in CML.
• Received a travel grant to attend SIOP 2010 in Boston and ESMO preceptorship in colorectal cancer (March 2015, Singapore).
• Invited as faculty and speaker at stem-cell/BMT conferences—e.g., KIMS Stem Cell Conference; guest lectures in Karimnagar and Hyderabad (2015–2016).

• Published a case report on plasma cell leukaemia presenting as hairy cell leukaemia in the Indian Journal of Haematology & Blood Transfusion (2013).

• Conducted a retrospective study on Imatinib Mesylate as first-line therapy in advanced-phase CML, published in the Indian Journal of Cancer (2014).

• Presented a poster on Imatinib Mesylate in CML at ASCO Chicago (2011), recognized among the best from India.

• Won 2nd prize for a retrospective analysis of adult acute promyelocytic leukemia at the ISMPO Vizag Meet (2012).

• Authored several abstracts and conference presentations at national and international forums, highlighting his dedication to hematologic cancer research.